Premium
P1‐315: Seizure susceptibility and hippocampal network hypersynchrony at a young age in a triple transgenic mouse model of Alzheimer's disease
Author(s) -
Kazim Syed Faraz,
Chuang Shih-Chieh,
Zhao Wangfa,
Iqbal Khalid,
Bianchi Riccardo
Publication year - 2015
Publication title -
alzheimer's and dementia
Language(s) - Czech
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2015.06.530
Subject(s) - hippocampal formation , bicuculline , genetically modified mouse , epilepsy , neuroscience , hippocampus , medicine , presenilin , gabaa receptor , stimulation , transgene , alzheimer's disease , psychology , disease , receptor , biology , gene , biochemistry
Cornelia Dorner-Ciossek, Scott Hobson, Klaus Fuchs, Achim Sauer, Margit Bauer, Angel Morales-Ramos, Shankar Venkatraman, Lawrence W. Dillard, Barbara Kruk, Lamont Howard, Yuri Bukhtiyarov, Yi Zhao, Deepak S. Lala, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; Boehringer Ingelheim Pharma GmbH & Co KG, Biberach a.d. Riss, Germany; Boehringer Ingelheim Pharma GmbH & Co KG, Ridgefield, CT, USA; Boehringer Ingelheim Pharma GmbH& Co KG, Biberach a. d. Riss, Germany; Boehringer-Ingelheim Pharma GmbH& Co KG, Biberach a.d. Riss, Germany; Vitae Pharmaceuticals Inc, Fort Washington, PA, USA. Contact e-mail: cornelia.dorner-ciossek@ boehringer-ingelheim.com